Alicia C. Beeghly, Ph.D. - Publications

Affiliations: 
2005 Yale University, New Haven, CT 
Area:
Public Health, Molecular Biology, Oncology

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Castellano CA, Sun T, Ravindranathan D, Hwang C, Balanchivadze N, Singh SRK, Griffiths EA, Puzanov I, Ruiz-Garcia E, Vilar-Compte D, Cárdenas-Delgado AI, McKay RR, Nonato TK, Ajmera A, Yu PP, ... ... Beeghly A, et al. The impact of cancer metastases on COVID-19 outcomes: A COVID-19 and Cancer Consortium registry-based retrospective cohort study. Cancer. PMID 38376917 DOI: 10.1002/cncr.35247  0.376
2023 Harris HR, Peres LC, Johnson CE, Guertin KA, Beeghly A, Bandera EV, Bethea TN, Joslin CE, Wu AH, Moorman PG, Ochs-Balcom HM, Petrick JL, Setiawan VW, Rosenberg L, Schildkraut JM, et al. Racial Differences in the Association of Endometriosis and Uterine Leiomyomas With the Risk of Ovarian Cancer. Obstetrics and Gynecology. PMID 37159277 DOI: 10.1097/AOG.0000000000005191  0.368
2022 He J, Wen W, Beeghly A, Chen Z, Cao C, Shu XO, Zheng W, Long Q, Guo X. Integrating transcription factor occupancy with transcriptome-wide association analysis identifies susceptibility genes in human cancers. Nature Communications. 13: 7118. PMID 36402776 DOI: 10.1038/s41467-022-34888-0  0.339
2010 Lu L, Katsaros D, Qian B, Preti M, Menato G, Beeghly A, Yu H. Abstract 834: IGF-II promoter specific methylation patterns are associated with its expression and disease progression in epithelial ovarian cancer Cancer Research. 70: 834-834. DOI: 10.1158/1538-7445.Am10-834  0.597
2007 Beeghly AC, Katsaros D, Wiley AL, Rigault de la Longrais IA, Prescott AT, Chen H, Puopolo M, Rutherford TJ, Yu H. IGF-II promoter methylation and ovarian cancer prognosis. Journal of Cancer Research and Clinical Oncology. 133: 713-23. PMID 17569086 DOI: 10.1007/S00432-007-0211-3  0.534
2006 Wiley A, Katsaros D, Chen H, Rigault de la Longrais IA, Beeghly A, Puopolo M, Singal R, Zhang Y, Amoako A, Zelterman D, Yu H. Aberrant promoter methylation of multiple genes in malignant ovarian tumors and in ovarian tumors with low malignant potential. Cancer. 107: 299-308. PMID 16773633 DOI: 10.1002/Cncr.21992  0.568
2006 Beeghly A, Katsaros D, Chen H, Fracchioli S, Zhang Y, Massobrio M, Risch H, Jones B, Yu H. Glutathione S-transferase polymorphisms and ovarian cancer treatment and survival Gynecologic Oncology. 100: 330-337. PMID 16199080 DOI: 10.1016/J.Ygyno.2005.08.035  0.495
2004 Jones BA, Kasl SV, Howe CL, Lachman M, Dubrow R, Curnen MM, Soler-Vila H, Beeghly A, Duan F, Owens P. African-American/White differences in breast carcinoma: p53 alterations and other tumor characteristics. Cancer. 101: 1293-301. PMID 15368321 DOI: 10.1002/Cncr.20500  0.31
2002 Jones B, Kasl S, Soler H, Van Ness P, Howe C, Lachman M, Beeghly A, Dallal C, Duan F. #11 Race / ethnic differences in breast cancer survival Annals of Epidemiology. 12: 493-494. DOI: 10.1016/S1047-2797(02)00299-5  0.437
Show low-probability matches.